Labcorp enhances clinical trial and drug development capabilities through real world data collaboration with healthverity

Burlington, n.c.--(business wire)--labcorp® (nyse: lh), a leading global life sciences company, today announced a new collaboration with healthverity, inc., the leader in identity, privacy, governance, and exchange (ipge) for real-world data (rwd), that will expand labcorp's comprehensive, end-to-end drug development and clinical trial programs. healthverity's ipge platform, an integrated technology and rwd infrastructure, enables labcorp drug development and other participating companies to ac
LH Ratings Summary
LH Quant Ranking